EA200501625A1 - Интерферон-бета при тяжелом остром респираторном синдроме (sars) - Google Patents
Интерферон-бета при тяжелом остром респираторном синдроме (sars)Info
- Publication number
- EA200501625A1 EA200501625A1 EA200501625A EA200501625A EA200501625A1 EA 200501625 A1 EA200501625 A1 EA 200501625A1 EA 200501625 A EA200501625 A EA 200501625A EA 200501625 A EA200501625 A EA 200501625A EA 200501625 A1 EA200501625 A1 EA 200501625A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- sars
- interferon
- syndrome
- beta
- respirator
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
В настоящем изобретении раскрыто применение интерферона (IFN) для производства лекарственного средства, предназначенного для лечения и/или профилактики тяжелого острого респираторного синдрома (SARS).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03101066 | 2003-04-17 | ||
PCT/EP2004/050456 WO2004091653A1 (en) | 2003-04-17 | 2004-04-06 | Interferon beta in severe acute respiratory syndrome (sars) |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200501625A1 true EA200501625A1 (ru) | 2006-04-28 |
EA008766B1 EA008766B1 (ru) | 2007-08-31 |
Family
ID=33185950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200501625A EA008766B1 (ru) | 2003-04-17 | 2004-04-06 | Интерферон-бета при тяжелом остром респираторном синдроме (sars) |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070026014A1 (ru) |
EP (1) | EP1613342A1 (ru) |
JP (1) | JP2006523655A (ru) |
KR (1) | KR20050112127A (ru) |
CN (1) | CN1798572A (ru) |
AU (1) | AU2004229185A1 (ru) |
BR (1) | BRPI0409484A (ru) |
CA (1) | CA2521650A1 (ru) |
EA (1) | EA008766B1 (ru) |
MX (1) | MXPA05011170A (ru) |
NO (1) | NO20055243L (ru) |
UA (1) | UA81481C2 (ru) |
WO (1) | WO2004091653A1 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006528679A (ja) * | 2003-04-01 | 2006-12-21 | インターミューン インコーポレイテッド | コロナウイルス感染症及びサースを治療するための組成物及び方法 |
EP1641485A4 (en) * | 2003-06-09 | 2009-06-24 | Genome Inst Of Singapore | INHIBITION OF SARS CORONAVIRUS INFECTION USING ANTIVIRAL DRUGS CLINICALLY TESTED |
US9295669B2 (en) | 2010-12-14 | 2016-03-29 | Hoffman La-Roche Inc. | Combination therapy for proliferative disorders |
CA3180390A1 (en) * | 2020-03-27 | 2021-09-30 | Fergus MANFORD | Compositions for the treatment of a respiratory condition |
US20220125661A1 (en) * | 2020-10-22 | 2022-04-28 | Jacob Waterman | Patient-Worn Therapeutic Apparatus |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
JP5281726B2 (ja) * | 1998-05-15 | 2013-09-04 | メルク・シャープ・アンド・ドーム・コーポレーション | 慢性C型肝炎感染を有する、抗ウイルス処置を受けていない患者における、リバビリンおよびインターフェロンαを含む併用療法 |
JP2002220343A (ja) * | 2001-01-26 | 2002-08-09 | Toray Ind Inc | びまん性肺疾患延命剤 |
US20030143199A1 (en) * | 2001-10-09 | 2003-07-31 | Carson Dennis A. | Use of STAT-6 inhibitors as therapeutic agents |
US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
US20050137154A1 (en) * | 2003-05-16 | 2005-06-23 | Hemispherx Biopharma | Treating server acute respiratory syndrome |
-
2004
- 2004-04-06 KR KR1020057019312A patent/KR20050112127A/ko not_active Application Discontinuation
- 2004-04-06 JP JP2006505526A patent/JP2006523655A/ja active Pending
- 2004-04-06 CA CA002521650A patent/CA2521650A1/en not_active Abandoned
- 2004-04-06 US US10/553,135 patent/US20070026014A1/en not_active Abandoned
- 2004-04-06 BR BRPI0409484-0A patent/BRPI0409484A/pt not_active IP Right Cessation
- 2004-04-06 EA EA200501625A patent/EA008766B1/ru not_active IP Right Cessation
- 2004-04-06 AU AU2004229185A patent/AU2004229185A1/en not_active Abandoned
- 2004-04-06 EP EP04725948A patent/EP1613342A1/en not_active Withdrawn
- 2004-04-06 CN CNA2004800146510A patent/CN1798572A/zh active Pending
- 2004-04-06 MX MXPA05011170A patent/MXPA05011170A/es not_active Application Discontinuation
- 2004-04-06 WO PCT/EP2004/050456 patent/WO2004091653A1/en active Application Filing
- 2004-06-04 UA UAA200510856A patent/UA81481C2/uk unknown
-
2005
- 2005-11-08 NO NO20055243A patent/NO20055243L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20050112127A (ko) | 2005-11-29 |
EA008766B1 (ru) | 2007-08-31 |
US20070026014A1 (en) | 2007-02-01 |
NO20055243L (no) | 2005-11-08 |
JP2006523655A (ja) | 2006-10-19 |
AU2004229185A1 (en) | 2004-10-28 |
BRPI0409484A (pt) | 2006-05-02 |
MXPA05011170A (es) | 2005-12-14 |
EP1613342A1 (en) | 2006-01-11 |
CN1798572A (zh) | 2006-07-05 |
UA81481C2 (en) | 2008-01-10 |
CA2521650A1 (en) | 2004-10-28 |
WO2004091653A1 (en) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402594A2 (hu) | Rapamycint és származékait tartalmazó hatóanyag-leadó rendszerek érbetegségek megelőzésére és kezelésére | |
HUP0301444A2 (hu) | Ribavirin és pegilezett alfa-interferon alkalmazása HCV fertőzés kezelésére szolgáló gyógyszerkészítmény előállítására | |
IL160420A0 (en) | Treating or preventing diabetes with cannabidiol | |
IL173002A (en) | Use of calcitonin in the manufacture of oral medication for the prevention or treatment of osteoarthritis | |
ATE460942T1 (de) | Exendine zur glucagon suppression | |
EA200600498A1 (ru) | Макроциклические пептиды, проявляющие противовирусную активность в отношении вируса гепатита с | |
ZA200407813B (en) | Medicament for preventing and/or treating chronic rejection. | |
TW200509961A (en) | Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections | |
WO2004006756A3 (en) | THERAPIES FOR RENAL FAILURE USING INTERFERON-β | |
AR045870A1 (es) | Terapia de combinacion para la infeccion de virus de hepatitis c | |
NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
NO20073632L (no) | Behandling av hepatitt C med interferon-beta i en asiatisk populasjon | |
UY28080A1 (es) | Isómeros posicionales del ifn peg alfa 2a | |
WO2007057436A3 (en) | Interferon in influenza | |
PT1610787E (pt) | Associação sinérgica compreendendo roflumilast e um agente anticolinérgico seleccionado de sais de tiotrópio para o tratamento de doenças respiratórias | |
ZA200502464B (en) | Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome. | |
WO2004062684A3 (en) | Treatment of thrombocytopenia with inhibitors of pacap | |
ES1053382Y (es) | Protesis dilatadora del vestibulo nasal. | |
WO2004091524A3 (en) | Respiratory virus vaccines | |
EA200501625A1 (ru) | Интерферон-бета при тяжелом остром респираторном синдроме (sars) | |
WO2005123113A3 (en) | Interferon compositions and methods of use thereof | |
DE69918961D1 (de) | Verbesserte inhalationspräparate | |
EA200500774A1 (ru) | Новая синергетическая комбинация, включающая рофлумиласт и формотерол | |
WO2005034853A3 (en) | Uses of interferons with altered spatial structure | |
EE200300213A (et) | SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |